Prosecution Insights
Last updated: November 11, 2026

Vivitro Labs Inc.

Technology area: Semiconductors, Circuits & Optics

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Vivitro Labs Inc. has 1 pending office action in Semiconductors, Circuits & Optics. The matter involves 1 distinct examiner and 1 distinct art unit, producing a single, concentrated prosecution path.

DUNLAP, JONATHAN M is the busiest examiner, with 1 pending matter. There is no broader examiner or art-unit distribution to evaluate. Counsel can therefore concentrate on the precise claim issues in the pending record and tailor the response to this examiner’s examination context.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
100% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DUNLAP, JONATHAN M 1 76.1% +16.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18715670 CARDIAC DEVICE TESTING DUNLAP, JONATHAN M —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18715670 CARDIAC DEVICE TESTING DUNLAP, JONATHAN M —

Top Art Units

Art UnitApps
2855 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18715670 CARDIAC DEVICE TESTING DUNLAP, JONATHAN M 2855 §102§103§112 Non-Final OA — Pending May 31, 2024

Managing Vivitro Labs Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Vivitro Labs Inc. have?

Vivitro Labs Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Vivitro Labs Inc. applications?

Jonathan M Dunlap has the most, with 1 of Vivitro Labs Inc.'s pending office actions.

What technology area are Vivitro Labs Inc.'s patent applications in?

Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month